CFLAR and non-small cell lung carcinoma: The squamous non-small cell lung cancer (NSCLC) cell line, H1703, either mock-transfected or carrying the long form c-FLIP-(L), were initially treated with or without the TRAIL ligand in order to evaluate the influence of c-FLIP(L) on apoptosis.